These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 21396903
1. Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district. Cristiani C, Tuccori M, Pepe P, Sarteschi A, Maddalo F, Simonini G, Michi P, Consigli V, Fornai M, Antonioli L, Blandizzi C. Vaccine; 2011 Apr 18; 29(18):3443-8. PubMed ID: 21396903 [Abstract] [Full Text] [Related]
3. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. Esposito S, Pugni L, Daleno C, Ronchi A, Valzano A, Serra D, Mosca F, Principi N. Pediatrics; 2011 May 18; 127(5):e1161-8. PubMed ID: 21464195 [Abstract] [Full Text] [Related]
4. An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria in a province of Emilia-Romagna region, Italy - part one. Candela S, Pergolizzi S, Ragni P, Cavuto S, Nobilio L, Di Mario S, Dragosevic V, Groth N, Magrini N, SaFoH1N1 working group. Vaccine; 2013 Feb 27; 31(10):1431-7. PubMed ID: 22766247 [Abstract] [Full Text] [Related]
6. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents. Esposito S, Tagliaferri L, Daleno C, Valzano A, Picciolli I, Tel F, Prunotto G, Serra D, Galeone C, Plebani A, Principi N. Vaccine; 2011 Feb 11; 29(8):1677-82. PubMed ID: 21199699 [Abstract] [Full Text] [Related]
7. Vaccines against influenza A (H1N1) pandemic. Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP. Arch Med Res; 2009 Nov 11; 40(8):693-704. PubMed ID: 20304259 [Abstract] [Full Text] [Related]
10. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden. Ortqvist A, Berggren I, Insulander M, de Jong B, Svenungsson B. Clin Infect Dis; 2011 May 11; 52(10):1203-11. PubMed ID: 21507917 [Abstract] [Full Text] [Related]
11. Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children. Scheifele DW, Ward BJ, Dionne M, Vanderkooi O, Langley JM, Dobson S, Li Y, Law B, Halperin SA, Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Rapid Trials Investigators. Pediatr Infect Dis J; 2011 May 11; 30(5):402-7. PubMed ID: 21178654 [Abstract] [Full Text] [Related]
12. A population based cohort study to assess the safety of pandemic influenza vaccine Focetria in Emilia-Romagna region, Italy - part two. Moro ML, Nobilio L, Voci C, Di Mario S, Candela S, Magrini N, SaFoH1N1 working group. Vaccine; 2013 Feb 27; 31(10):1438-46. PubMed ID: 22885015 [Abstract] [Full Text] [Related]
15. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Bone A, Guthmann JP, Nicolau J, Lévy-Bruhl D. Vaccine; 2010 Nov 29; 28(51):8157-61. PubMed ID: 20937310 [Abstract] [Full Text] [Related]
20. Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children. Yasuda Y, Komatsu R, Matsushita K, Minami T, Suehiro Y, Sawata H, Nakura N, Jaeger RK, Lattanzi M. Adv Ther; 2010 Jul 29; 27(7):444-57. PubMed ID: 20586002 [Abstract] [Full Text] [Related] Page: [Next] [New Search]